Diastasis Recti Abdominis Association With Sacroiliac Joint and Pelvic Floor Dysfunction in Postp… (NCT04519840) | Clinical Trial Compass
CompletedNot Applicable
Diastasis Recti Abdominis Association With Sacroiliac Joint and Pelvic Floor Dysfunction in Postpartum C-section Women
United Arab Emirates32 participantsStarted 2020-12-15
Plain-language summary
Purpose: The purpose of the proposed study is to examine the ability of diastasis recti abdominis to predict outcomes of Sacroiliac joint dysfunction and pelvic floor dysfunction.
* Sample: The study will use a purposive sampling to select 120 subjects, ages 18-45, in the postpartum period between 12 weeks and 48 weeks. All subjects should have resided in the UAE minimum of 6 months prior to taking part in the study.
Data analysis:
* The age range of the subjects as well as the mean age with standard deviation will be determined.
* Data will be analyzed using Multivariate Linear Regression Analysis for the primary research question.
* For the Ssecondary research questions will include difference in DRA will be analyzed byas below:
* SIJ Dysfunction (logistic regression-Odds ratio)
* PFDI (Low, Moderate, High) (ANOVA/Kruskal Wallace Wallis Test)
* Pelvic Fascia excursion (Low, Moderate, High). (ANOVA/Kruskal Wallace Wallis Test)
Who can participate
Age range
18 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Eligible participant should be 12-48 weeks postpartum between ages of 18-45 years
* Maximum two Cesarean section delivery with no vaginal deliveries.
Exclusion Criteria:
* ● Participant will be excluded (identified with the assistance of a health screening questionnaire):
* History of traumatic injury to the lumbar-pelvic region, hip or lower extremities
* Morbid Obesity: Participants with more than 35 kg/m2 body mass index will be excluded.
* History of systemic disease affecting the musculoskeletal, neuromuscular and cardiopulmonary systems
* Cardiovascular disease affecting lung function.
* History of traumatic injury to the lumbar-pelvic region, hip or lower extremities.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.